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a New Field 
I
magine the most sophisticated engineering 
feat you can think of, and you might not 
consider a living cell. And yet cells are fabu-
lously sophisticated, able to produce all the 
proteins, tissues, and biological circuits that give rise 
to life. Scientists have spent hundreds of years just try-
ing to understand cells and to work with them as they 
were created by nature. Now it’s becoming possible to 
“rewire” cells using genetic circuits, protein pathways, 
and other bio  molecular machinery created in the labo-
ratory. By swapping out natural genetic circuitry for 
synthesized components made of DNA, scientists are 
putting cells to work as sensors and as miniature fac-
tories that make pharmaceuticals, fuels, and industrial 
chemicals. 
These possibilities not only blur the lines between 
engineering and biology but also are transforming how 
scientists approach challenges in energy, human health, 
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biomedical systems engineering at Impe-
rial College of Science, Technology, and 
Medicine in London, England, believes the 
field’s influence could rival or exceed that 
of synthetic chemistry, which made modern 
pharmaceuticals, detergents, plastics, and 
computer semiconductors possible. “We’re 
talking about harnessing cells—which I 
describe as the ultimate manufacturing 
units—to carry out human-controlled pro-
cesses,” says Kitney. “And that’s a completely 
new world with many up sides.” 
David Rejeski, who directs the Science 
and Technology Innovation Program at the 
Woodrow Wilson International Center for 
Scholars in Washington, DC, predicts a 
steady convergence of nanotechnology and 
synthetic biology will redefine manufactur-
ing over the next 100 years. “It’s a profound 
change—the next Industrial Revolution,” 
he says. “Precision control of matter at the 
nanoscale will change the way we produce 
just about everything, from electronics to 
drugs, fuels, materials, and food.”
Defining the Field
Despite that potential—or perhaps because 
of it—this new field of synthetic biol-
ogy suffers from an identity crisis. Ask 
10 experts to define “synthetic biology,” 
and you’re liable to get 10 different answers. 
The field overlaps with genetic engineering, 
which involves adding or deleting single 
genes, and also with metabolic engineer-
ing, which allows scientists to optimize 
cellular processes to produce desired sub-
stances, such as hormones. Pamela Silver, 
a professor of systems biology at Harvard 
Medical School and a core faculty member 
with Harvard University’s Wyss Institute 
for Biologically Inspired Engineering, says 
synthetic biology embraces metabolic engi-
neering but also diverges from it by relying 
on modular components made from DNA. 
Scientists can now synthesize genes from 
DNA subunits arranged to user specifica-
tions. Those genes are then strung together 
into components and devices that cells, 
under laboratory conditions, can absorb 
into their chromosomes. 
In what’s seen as a major proof of con-
cept for the field, scientists at Amyris Bio-
technologies in Emeryville, California, 
rewired 12 genes in yeast so the organism 
would produce artemisinin, an antimalarial 
drug. On the environmental front, scientists 
are also rewiring algae and other organisms 
to make biofuels for the transportation sec-
tor. Eric Toone, a professor of chemistry and 
of biochemistry at Duke University, says that 
without synthetic biology it’s unlikely bio-
fuels could ever be produced at the volumes 
and prices needed to compete economically 
with gasoline, diesel, or jet fuel.
But if synthetic biology is exciting, it’s 
also unsettling to those concerned about its 
risks. Engineered microbes might escape 
and propagate in the wild with unforeseen 
consequences, some say. Others caution 
that synthetic biology has high potential for 
abuse. Customized DNA sequences deliv-
ered through the mail can now be bought 
for just 40¢ per base pair. Gene synthesis 
companies aren’t legally obligated to screen 
their customers, so it’s possible terrorists 
could make viral bioweapons from scratch, 
says Pat Mooney, executive director with the 
ETC Group in Ottawa, Canada.  
Jay Keasling, a professor of chemical 
engineering at the University of California, 
Berkeley, who pioneered the artemisinin 
research, openly acknowledges the field’s 
potential hazards. “The worst thing that 
could happen is someone gets hurt from syn-
thetic biology,” he says. “But we’re also talk-
ing about applications that justify the field 
going forward in a major way.” Like other 
proponents of the field, Keasling frames 
synthetic biology’s potential in terms of how 
it can help solve humanity’s worst problems, 
many of which are tightly intertwined with 
environmental health: energy shortages, pol-
lution, hunger, and disease.
“We’re headed towards a global popula-
tion of nine billion in just thirty-five years, 
up from six billion today,” adds Craig Venter, 
who famously led private efforts to decode 
the human genome, and who now heads the 
J. Craig Venter Institute, a genomics-based 
research organization. “Our . . . hope is that 
[synthetic biology] works so that we don’t 
have to constantly destroy the environment 
to produce more food. The same applies to 
fuel—we need intelligent solutions.”
A Focus on Biofuels
Given pricing, security, and pollution con-
cerns regarding fossil fuels, biofuels rank 
high as a priority use for synthetic biology; 
figures collected by Rejeski’s team show the 
Department of Energy spent over $305 mil-
lion on synthetic biology research in fiscal 
year 2009 with a similar amount projected 
for this year. (By comparison, the Depart-
ment of Health and Human Services spent 
roughly $19 million in the field in fiscal 
year 2009 and has yet to determine its 2010 
outlay.) 
Unlike fossil fuels, which release long-
sequestered carbon dioxide (CO2) into the 
atmosphere when burned, plant-based bio-
fuels are carbon-neutral, meaning the car-
bon they release during burning was cap-
tured from the air during photosynthesis. 
The first-generation fuels available now—
namely, corn-based ethanol, biodiesel, and 
other fuels derived from food crops—have 
been impractical as energy sources, Toone 
says. Ethanol is corrosive and miscible with 
water, so it can’t be transported by pipeline. 
And biodiesel can’t burn in gasoline engines, 
which power most of the vehicles on the 
road. What’s more, first-generation fuels are 
linked to instabilities in food pricing and 
also with deforestation in tropical coun-
tries [for more information, see “Food vs. 
Fuel: Diversion of Crops Could Cause More 
Hunger,” EHP 116:A254–A257 (2008)]. 
Next-generation biofuels generated from 
nonfood sources such as algae, cyano  bacteria, 
and switchgrass—a weedy plant that grows 
on marginal lands, generating enormous bio-
mass without much water—will ideally be 
produced more efficiently, relieving some 
pressure on agriculture. Scientists are engi-
neering cells that secrete fuel intermediates 
(such as lipids and fatty acids) that can be 
refined into fuels. This past July, ExxonMobil 
contributed $600 million to Venter’s new 
startup company, Synthetic Genomics, Inc., 
T
he field of synthetic biology was launched 
by  a  pair  of  papers  published  in  the 
20  January  2000  issue  of  Nature.  The 
first—by  Michael  B.  Elowitz  and  Stanislas 
Leibler—presented a synthetic genetic oscillator. 
The other—by Timothy S. Gardner, Charles R. Cantor, 
and James J. Collins—presented a synthetic genetic 
toggle switch, showing that it was feasible to model, 
design, and construct synthetic gene networks out 
of bio  molecular components.Focus | Synthetic Biology
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with the aim of extracting “biocrude” from 
photosynthetic algae that can be refined into 
gasoline, diesel, and jet fuel. 
Venter’s approach draws on the concept 
of making biofuel directly from CO2 in the 
atmosphere. Photosynthetic organisms such 
as algae fix CO2 from the air; then, using 
light (as an energy source) and hydrogen from 
water vapor, they reduce this CO2 to an ener-
gy-rich product: glucose. A sugar, glucose 
is loaded with carbon–carbon bonds. And 
during respiration, those bonds are broken 
down into lipids and other energy-rich hydro-
carbons that could ideally be refined into 
transportation fuel. 
By changing the algae’s genetic struc-
ture, Venter and his colleagues aim to make 
different types of hydrocarbons, more like 
those found in fossil fuels. Given proprietary 
concerns, Venter won’t comment on how 
his company is rewiring the algae. He says 
only that they’re “engineered to continuously 
pump hydrocarbons out into media [rather 
than accumulating them], making them pro-
duction machines rather than something we 
grow just to kill or harvest.” 
James Liao, a professor of chemical and 
biomolecular engineering at the University of 
California, Los Angeles, hopes to avoid refin-
ing altogether by engineering photosynthetic 
cyanobacteria that make engine-compatible 
fuels. As described in the December 2009 
issue of Nature Biotech  nology, Liao and col-
leagues divert cell pathways normally involved 
in amino acid synthesis so that instead they 
produce alcohol—namely, butanol, which 
Liao says can go directly into current-day 
internal combustion engines. “The good 
thing about algae and cyanobacteria is that 
they don’t require agricultural land,” Liao 
adds. “We can use coastal areas.”
Writing in the same issue of Nature Bio-
technology, John Sheehan, a scientific pro-
gram coordinator at the Institute on the 
Environment at the University of Minne-
sota, described Liao’s production volumes as 
“impressive,” pointing out they’re “five to six 
times better than industrially relevant esti-
mates for corn and cellulosic ethanol produc-
tion, and even outperform current estimates 
for algal oil productivity.” 
Still, Liao acknowledges that even with 
these high yields, photosynthetic microbes 
would have to be cultivated on millions of 
acres to offset gasoline and other liquid fossil 
fuels. That’s in part because photons pen-
etrate just 10 cm into the ponds and bio-
reactors where the microbes are grown. 
Toone, who directs biofuels research 
at the Department of Energy’s Advanced 
Research Projects Agency—Energy (more 
commonly known as ARPA-E), agrees that 
biofuels derived from photosynthesis will 
require enormous land area regardless of 
whether energy crops or microbes are used. 
“And that brings us to another option that 
hasn’t been explored yet: using nonphotosyn-
thetic organisms to make liquid fuels from 
carbon dioxide,” Toone says.  
Nonphotosynthetic  microbes  take 
energy from sources other than light, such as 
charged ions in certain metals. But like their 
photosynthetic counterparts, these organ-
isms don’t produce traditional fuel com-
pounds—acetogenic microbes, for instance, 
make acetate during respiration, while 
methanogens produce methane. “We need 
synthetic biology to install new pathways 
so that these organisms start producing the 
fuels we’re interested in,” Toone says. “The 
bugs could go anywhere, even underground, 
and you don’t have to spread them so thinly 
because they don’t [rely on] photons.”
Robert Kelly, director of the biotech-
nology program at North Carolina State 
University, suggests that energy for nonphoto-
synthetic organisms could come from hydro-
gen, which some anaerobic microbes use to 
reduce CO2 into more complex carbon-based 
molecules. Toone adds that some microbes 
could be engineered to use electricity as an 
energy source. “You could generate that elec-
tricity from solar panels, nuclear power, even 
wind and wave action,” he says.
None of the bewildering array of options 
for making next-generation fuels are ready 
for prime time yet. And those deemed most 
promising will also have to contend with 
three core challenges, according to James 
Collins, a professor of bio  engineering at 
Boston University and a Wyss Institute 
core member. “The first [challenge] is 
scale—you need to get production up to 
industrial levels,” Collins says. “The sec-
ond is efficiency, because as the size of your 
operation grows, your fuel yield will likely 
decrease. And the third is economics. You 
can’t expect a viable business model if it costs 
you four dollars to make a dollar’s worth of 
gas. Failure to overcome any one of these 
limitations is likely to kill your project.”
Robert Carlson, a principal at Bio  desic, 
a bioengineering design firm in Seattle, 
Washington, doesn’t necessarily see scale as 
a dealbreaker when it comes to commercial-
izing biofuel applications. On the contrary, he 
wrote in a 23 February 2009 essay titled “The 
New Biofactories,” synthetic biology could 
enable the production of fuel within cars 
themselves: “In the spring of 2007, researchers 
reported the successful construction of a syn-
thetic pathway consisting of 13 enzymes from 
different organisms that can turn starch into 
hydrogen,” he wrote. “This suggests a future 
in which sugar or starch—substances avail-
able at any grocery store—will go into our 
fuel tanks instead of gasoline.” 
Kelly adds that no one approach is likely 
to serve as a silver bullet that replaces fos-
sil fuels altogether. “We’re not going to be 
locked into any one system,” he says. 
Synthetic Microbes for Bioremediation
Apart from new fuels, better hazardous waste 
cleanup is also cited as one of synthetic biolo-
gy’s environmental promises. Bioremediation 
is already common in oil spill cleanups; Rho-
dococcus and Pseudomonas bacteria, among 
Researchers currently are aiming to produce 100 g of biofuel per m2 per day from 
algae and cyanobacteria—about 10 times the output achieved so far. Equaling current 
U.S. demand for gasoline would require millions of acres if using photosynthetic algae, 
but novel strains of nonphotosynthetic algae can be grown in fermentation bioreactors 
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others, naturally consume and degrade 
many petroleum components into less toxic 
by-products. Using engineered microbes to 
degrade more recalcitrant chemicals such 
as dioxins, pesticides, or even radioactive 
compounds could save millions of dollars 
otherwise spent on excavating and trucking 
polluted soils to hazardous waste landfills, 
according to Gary Sayler, who heads the 
Center for Environmental Biotechnology at 
the University of Tennessee in Knoxville. But 
research in this area—under development for 
more than 2 decades—has yet to get out of 
the laboratory, Sayler says. Fearing uncertain 
environmental consequences, activists have 
routinely lined up against releasing engi-
neered microbes for cleanup, and the U.S. 
Environmental Protection Agency (EPA) 
has subjected the organisms to extensive risk-
assessment protocols. 
Today, health agencies are more willing 
to consider genetically engineered microbes 
in cleanup, Sayler says, but even so, the 
infrastracture needed to proceed isn’t avail-
able, and neither is the funding. Syn  thetic 
biology might offer new opportunities, he 
adds, but scientists need to explore how 
degradation pathways developed mainly in 
Escherichia coli research will work in other 
microbes better suited for survival in pol-
luted sites.
A leading scientist in this area is Victor 
de Lorenzo, head of the Laboratory of 
Environmental Molecular Microbiology at 
Spain’s National Center for Biotechnology. 
De Lorenzo uses robust microbes that sur-
vive in harsh conditions—for instance, the 
soil bacterium Pseudomonas putida—which 
he then “edits” genomically by replacing 
nonessential genes with engineered meta-
bolic and regulatory circuits that degrade 
target compounds. These new circuits direct 
microbes away from easy carbon sources 
such as glucose, he says, and toward more 
challenging food sources in industrial chem-
icals. “In other words, we’re uncoupling 
metabolism from the microbe’s own physi-
ology,” he explains.
By removing all nonessential genes, 
de Lorenzo can create what’s known as a 
reduced genome, or a minimized cell. As 
blank slates that scientists can program by 
adding new genes, these constructs define a 
leading edge for synthetic biology. 
Apart from making minimal cells by 
deleting unnecessary genes, scientists can 
also generate them by booting up voided 
cells (whose own chromosomes have been 
removed) with entirely new genomes assem-
bled from scratch. This is the approach 
Venter is taking now. In 2008, he and his 
research team accomplished one of syn  thetic 
biology’s biggest feats: they synthesized the 
entire genome—485 coding genes—for 
Mycoplasma genitalium, a simple bacterium. 
According to Venter, at least 115 of those 
genes are nonessential and can be deleted 
without harming the genome’s functionality. 
Venter’s team is now trying to use a synthetic 
bacterial genome to boot up the voided cell 
of a related species, M. capricolum.
So far, as reported in the 25 Septem-
ber 2009 issue of Science, they haven’t suc-
ceeded. Venter explains that M. capricolum 
rejected the new genome in much the same 
way it might reject a virus. “We’re developing 
methods to sidestep this problem,” he says. 
Among those methods: removing the restric-
tion enzymes that M. capricolum uses to slice 
up foreign genetic material (which led to the 
recent failure) or attaching methyl groups to 
the synthetic genome to protect it in the cell. 
If successful, Venter and his colleagues will 
produce a minimal cell possessing only the 
genes needed for life.
Whether such a cell would constitute a 
synthetic life form—as some have claimed—
is up for debate, however. Petra Schwille, 
a professor at the Biotechnology Center of 
the Dresden University of Technology, says 
Venter’s microbe isn’t synthetic life so much as 
something more analogous to an inter  species 
clone. “He’s inserting the genome from one 
organism into the chassis of another,” she 
explains. That’s different from synthesizing 
an entire living cell from fatty acids and pro-
teins. To me, this is more like a bacterial 
robot than a type of synthetic life.” 
Venter emphasizes that his ambition in 
making this type of cell has always been to 
use them as platforms for understanding 
fundamental living processes. Still, Silver 
emphasizes that regardless of how they’re 
made, minimal cells could also be used as 
basic manufacturing platforms. Just like a 
computer’s functionality depends on the 
software you put into it, she explains, a 
minimal cell’s functionality would depend 
on its synthetic circuits. “If you want to 
make fuel or drugs, you still use this as your 
platform organism,” she says. “It’s essentially 
a universal chassis onto which you layer 
everything else.”
Regulating the Future
Meanwhile, experts disagree on how risky 
any of these engineered microbes might be. 
Keasling argues they don’t compete well in 
the wild and, moreover, that scientists can 
engineer the organisms to die when their 
task is complete—for instance, after the 
nutrient pollutants they feed on run out. 
And Collins has created DNA counters that 
commit cells to death after they replicate a 
few times. 
Still, as Rejeski wrote in the January/
February 2010 issue of The Environmental 
Forum, “One important lesson from the last 
Industrial Revolution is that the winners in 
this technological arms race are not neces-
sarily good for the environment.” Synthetic 
biology promises a galaxy of molecules and 
systems that are “specifically engineered to 
respond to the external environment (for 
instance, change structure and behavior in 
response to light, electromagnetic fields, 
pH, or other conditions), or actually self-
assemble into entirely new structures,” he 
F
or those who aren’t familiar with synthetic biol-
ogy, the term can conjure images of scientists 
creating artificial life—monsters, perhaps—in 
the laboratory. Newspaper headlines can feed those 
perceptions—a 2008 report by th Woodrow Wilson 
International Center for Scholars, Trends in American 
and European Press Coverage of Synthetic Biology: 
Tracking the Last Five Years of Coverage, found 
numerous media references to “playing God” or 
“copying God,” and even the phrase “Frankenstein-
like” to describe what’s emerging from the field. The 
reality isn’t quite so sensational; scientists aren’t 
creating new life from scratch so much as they are 
developing new ways to direct cell behavior.wrote. “These applications will be difficult 
to understand with traditional risk assess-
ment methods.”
Kitney says the interface between gene 
synthesis companies and the public will ulti-
mately form the front line for new regula-
tions. “Right now, the research community 
in this area is pretty small,” he says. “But 
as it gets larger—and I completely believe 
that it will—we’ll need to go from voluntary 
systems to more rigorous regulations that 
monitor potential threats.”
Mooney also cautions that biofuel devel-
opment could still compete unacceptably 
for agricultural resources and consolidate 
intellectual property in fuels and manu-
facturing in the hands of just a few com-
panies. The ETC Group’s October 2008 
report Commodifying Nature’s Last Straw? 
Extreme Genetic Engineering and the Post-
Petroleum Sugar Economy states, “Advocates 
of synthetic biology and the bio-based sugar 
economy assume that unlimited supplies of 
cellulosic biomass will be available. But can 
massive quantities of biomass be harvested 
sustainably without eroding/degrading soils, 
destroying biodiversity, increasing food inse-
curity and displacing marginalized peoples?” 
Moreover, the report states, simply “moving 
beyond petroleum” does not address high 
consumption patterns that drive many of 
these environmental ills. 
In Mooney’s view, the regulations gov-
erning synthetic biology now are wholly 
inadequate. That’s not to say the risks out-
weigh the potential benefits, he emphasizes. 
“We’re not talking about a failure of science 
but of governance in terms of its ability to 
track and regulate a powerful new technol-
ogy,” he explains. “This capacity to redesign 
life is vastly greater than what we normally 
associate with biotechnology.” 
As Rejeski put it in his Environmental 
Forum essay, “EPA and the other environ-
mental agencies have a once-in-a-century 
opportunity to place environmental policy 
and protection in front of a major shift in how 
we produce just about everything.” What’s 
needed, Rejeski says, is a central author-
ity that coordinates research and planning 
on synthetic biology. An analogous entity, he 
says, might be the National Nano  technology 
Coordination Office, which organizes federal 
research and development, public informa-
tion, and congressional hearings into that 
field. “There’s not enough public engage-
ment on the science of synthetic biology or its 
social and ethical implications, but from what 
we can tell in our focus groups and surveys, 
this is going to be a really contentious issue,” 
Rejeski says. “People react very negatively to 
the phrase ‘synthetic biology,’ and it’s going 
to be hard to thread the science through the 
needle of public opinion.” 
Still, Mooney lauds what he says is a 
remarkably open dialogue between scien-
tists and policy experts in the technology’s 
early days. “It can’t just be scientists mak-
ing all the decisions here,” he says. “We 
also need governments that represent the 
people, who can talk to the scientists and 
beyond them. I think if people have the 
chance to think these things through care-
fully, we’ll end up saying no in some cases, 
but in others, we’re going to want to know 
how we can use [synthetic biology] to solve 
problems.”
Charles W. Schmidt, MS, an award-winning science writer 
from Portland, ME, has written for Discover Magazine, 
Science, and Nature Medicine.
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Above: Rick Weiss of MIT and colleagues engineered E. coli “receiver” cells to evaluate 
how far they are from pink “sender” cells and report this distance by expressing a par-
ticular fluorescent protein (red or blue). The effect somewhat resembles embryo  genesis, 
in which the maternal environment provides such cues using chemical gradients.
Below: William Shih of Harvard and colleagues designed a single DNA strand that 
folds itself into a nanoscale octahedron using a technique called nano-origami. These 
minute structures could be used in molecular manufacturing, as structures that ferry drug 
molecules directly to diseased cells, or in X-ray crystallography.
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